BNT326 + ITRACONAZOLE for arthrogryposis

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 17 Jul 2025: Trial registered, NCT07070232
  2. 12 Aug 2025: Trial started, NCT07070232

The trials

NCT07070232: A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

State
Under way
Phase
Phase 1 and Phase 2
People
1,438 planned
Started
12 Aug 2025
Primary completion
Mar 2028
Arms
Part 1 (Cohort 1F, DDI) - BNT326 + itraconazole
Results
None posted
  1. 17 Jul 2025: Trial registered
  2. 12 Aug 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.